Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
, and susceptibility to interference. The objective of this 4-year PhD position is the production of a number of research articles in peer-reviewed scientific journals and conference proceedings, which
-
PhDGermany Find your suitable PhD opportunity in Germany. Find your suitable PhD opportunity in Germany. Back to Overview Next Working LanguageGerman, English LocationLüneburg Application Deadline30
-
the workgroup of Prof. Dr. Carsten Wolters at the Institute for Biomagnetism and Biosignalanalysis (IBB) (https://www.medizin.uni-muenster.de/biomag/das-institut.html) . Expected close collaborations and visits
-
Functionality, Implementation and Demonstration is currently searching for the second cohort of PhD candidates starting in Spring/Summer 2025. This program is an international collaboration between
-
group at University of Luxembourg, led by Prof. Jan Lagerwall (project coordinator), the Soft and Biofunctional Materials group at NOVA University Lisbon, Portugal, led by Prof. Maria Helena Godinho, and
-
by Prof. Holger Voos. Additionally, this industrial project will be conducted in partnership with the Proximus company as part of the IPBG ATLAS program. This PhD project aims to develop a solution for
-
of the PhD study programme, please see DTU's rules for the PhD education . Assessment The assessment of the applicants will be made by Dr. Lei Yang and Prof. Johannes Kabisch (Norwegian University of Science
-
challenge that all European countries are facing in the midst of the current energy crisis. We require a Research Assistant to support the work of Prof. Darren Evans and Prof. Gavin Stewart in the School
-
This 4-year PhD programme is fully funded for home students; the successful candidates will receive a tax free stipend based on the UKVI rate (£20,780 for 2025/26) and tuition fees will be paid
-
PhD Student (f/m/d) position at Leibniz Institute of Virology The Leibniz Institute of Virology (LIV) is an independent research institution for basic biomedical research. LIV is committed